Fusion Pharmaceuticals Inc. FUSN
Set alert
21.55 +21.55 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 1.83B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -12.68
- Beta
- -0.69
- Short ratio
- 6.22
- Inst. own
- 86.80%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 7, 2024
- 50-d avg
- 21.40
- 200-d avg
- 10.83
- 1y target
- 21.14
Analyst view
Consensus: hold
Hold
Price target (mean) 21.14 -1.9% downside
Now 21.55
- Target (low)
- 20.00
- Target (mean)
- 21.14
- Target (high)
- 23.00
Recommendation trend
- 1 month ago 13
- 2 months ago 14
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.34 | -0.38 – -0.29 | -0.38 | +10.5% | 240.00K | +200.0% | 4 |
| Next quarter | -0.35 | -0.41 – -0.28 | -0.25 | -40.0% | 230.00K | +130.0% | 4 |
| Current year | -1.51 | -1.79 – -1.25 | -1.45 | -4.1% | 580.00K | -72.0% | 5 |
| Next year | -1.70 | -1.93 – -1.34 | -1.51 | -12.6% | 560.00K | -3.4% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2, 2023 | B. Riley Securities | Reiterated | Buy | Buy |
| Sep 28, 2023 | Oppenheimer | Initiated | — | Outperform |
| Aug 27, 2023 | Raymond James | Maintained | Outperform | Outperform |
| Jun 27, 2023 | Wedbush | Reiterated | Outperform | Outperform |
| Jun 22, 2023 | Raymond James | Initiated | — | Outperform |
| Mar 29, 2023 | B. Riley Securities | Reiterated | — | Buy |
| Jan 26, 2023 | Morgan Stanley | Maintained | — | Overweight |
| Nov 29, 2022 | SVB Leerink | Initiated | — | Outperform |
| Sep 15, 2022 | Truist Securities | Initiated | — | Buy |
| Sep 6, 2022 | JonesTrading | Initiated | — | Buy |
| Jul 5, 2022 | William Blair | Initiated | — | Outperform |
| Aug 25, 2021 | B. Riley Securities | Initiated | — | Buy |
| Aug 17, 2021 | Morgan Stanley | Maintained | — | Overweight |
| May 17, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Apr 5, 2021 | Morgan Stanley | Maintained | — | Overweight |
| Jul 20, 2020 | Jefferies | Initiated | — | Buy |
| Jul 20, 2020 | Morgan Stanley | Initiated | — | Overweight |
| Jul 20, 2020 | Cowen & Co. | Initiated | — | Outperform |
| Jul 20, 2020 | Wedbush | Initiated | — | Outperform |